The Canadian Antimicrobial Resistance Surveillance System (CARSS) - 2017 Report executive summary is now available on Canada.ca. The full PDF technical report will be available in both official languages to download from the website by mid-December. In the interim, both the English and French PDF is available upon request by emailing firstname.lastname@example.org.
This year’s report provides a snapshot of 2015 and 2016 antimicrobial resistance (AMR) and use (AMU) data from the different Public Health Agency of Canada (PHAC) surveillance systems and its national laboratory reference services.
Although the overall level of AMR in Canada is similar or lower than rates reported by other developed countries, there are some areas of concern. Upward trends were seen in the rate of methicillin-resistant Staphylococcus aureus blood stream infection (BSI) in pediatric hospitals and the rate of vancomycin-resistant Enterococcus BSI in adults. In addition, the rate of drug-resistant gonorrhea increased between the years 2014 and 2015. There also remain significant data gaps that prevent our ability to provide a comprehensive picture of the current situation and emerging risks of AMR in Canada. Strengthening the surveillance of AMR and AMU in humans and animals is a priority for PHAC and the yearly CARSS Report serves to highlight the attained progress and future steps in addressing these gaps.